Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joel Horovitz is active.

Publication


Featured researches published by Joel Horovitz.


Obesity Surgery | 2005

Association of super-super-obesity and male gender with elevated mortality in patients undergoing the duodenal switch procedure.

Rafael M Fazylov; Richard H. Savel; Joel Horovitz; Murali Pagala; Gene F. Coppa; Jeffrey Nicastro; Richard S Lazzaro

Background: Previous studies have reported that risk factors for elevated mortality after Roux-en-Y gastric bypass include male gender, as well as a very elevated BMI. The present study was aimed at determining whether these same risk factors applied to patients undergoing the duodenal switch (DS) operation. Materials and Methods: A retrospective chart review was performed of a cohort of 385 patients who underwent DS. The 30-day mortality of super-superobese (SSO) patients [BMI ≥60 kg/m2 (n=102)] was compared with the mortality of the super- and morbidly obese (SMO) patients [35<BMI<60 kg/m2 (n=283)]. Results: Overall mortality in SSO patients was 7.8% (8/102), compared with 0% (0/283) in SMO patients undergoing the same procedure (P<0.001). When a gender-based subgroup analysis was performed in the SSO patients, men had a 16.7% mortality (7/42) while women had only a 1.7% (1/60) mortality. Conclusions: In this study of patients undergoing DS, being SSO – specifically SSO men – was associated with increased mortality. Further studies will be needed to better determine the precise mechanism of these risk factors leading to such an elevation in mortality. Until then, caution should be exercised before performing DS in male patients with BMI ≥60 kg/m2.


The American Journal of Gastroenterology | 2002

Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study

Zia Khan; Jane Vlodov; Joel Horovitz; Rose Mary Jose; Kadirawel Iswara; Joseph Smotkin; Alphonso Brown; Scott Tenner

OBJECTIVE:The management of patients with acute pancreatitis is complicated by the inability to distinguish mild from severe disease during the early stages. It has been previously shown that urinary trypsinogen activation peptide (TAP) and hematocrit (Hct) may serve as early predictors of severity in patients with acute pancreatitis. To establish which marker is more accurate in the determination of severity in patients with acute pancreatitis, a prospective study was performed.METHODS:A consecutive series of patients admitted with pain consistent with acute pancreatitis and an amylase of three times the upper limit of normal were included. The admission and 24-h Hct was obtained. A urine sample was obtained within 12 h of admission. Urinary TAP was determined using a modified solid phase ELISA. Severity was defined by the Atlanta Symposium, as the presence of organ failure and/or pancreatic necrosis.RESULTS:Fifty-eight consecutive patients with acute pancreatitis participated. There were 33 men and 25 women with a mean age of 60 ± 19. Thirty-nine patients had mild disease; 19 had severe disease. Urinary TAP was elevated in 26 patients. All patients with severe pancreatitis were correctly identified as having severe disease by an elevated urinary TAP (sensitivity 100%, specificity 77%). The admission Hct was higher than 47 in only three patients, all with mild disease. Of the patients with a rise in Hct, eight had mild disease, and only one had severe disease. Using a Hct of 44 as a cutoff did not affect the accuracy. There was no association between a rise in Hct and failure of Hct to decrease in the determination of severity.CONCLUSIONS:In comparison to admission Hct, urinary TAP was more accurate in determining severity in patients with acute pancreatitis by Atlanta, APACHE II, and Ranson criteria. We conclude that urinary TAP is a more accurate predictor of severity in patients with acute pancreatitis compared with Hct. Urinary TAP should be used to determine severity in patients early in the course of acute pancreatitis.


International Journal of Surgery | 2017

Aortic and splanchnic artery aneurysms: Unusual causes of biliary obstruction – A retrospective cohort from literature

Kevin Tin; Zain A. Sobani; Joel Horovitz; Rabin Rahmani

Mechanical obstruction of the biliary tree and resultant stasis are the cornerstone of a spectrum of diseases ranging from biliary colic to fulminant cholangitis. Infrequently acquired abnormalities of the abdominal vasculature can lead to biliary obstruction. In 2010, we reported a case of acute cholangitis resulting from compression of extra hepatic bile duct by an abdominal aortic aneurysm (AAA). We subsequently conducted a follow up scoping review of literature to identify other cases of acquired abdominal arterial abnormalities resulting in biliary obstruction looking at their management and outcomes. The articles were independently reviewed by two of the authors and pertinent data was extracted. The data was divided on an anatomic basis into two groups: one with primary aortic pathology and one with splanchnic vessel pathology. We identified 39 cases of biliary obstruction secondary to acquired aortic or splanchnic vessel abnormalities; 16 were caused by AAAs and 23 by splanchnic vessels. The cases were managed via conservative, endoscopic, endovascular or open surgical options based on the available technology and expertise. Although uncommon, recognition of aortic and splanchnic arterial abnormalities as a potential cause of biliary obstruction is important as management entails not only cautious decompression of the biliary tree but also addressing the underlying vascular pathology. We recommend that extrinsic biliary compression by an aneurysm or pseudoaneurysm be considered among the differential diagnosis in patients presenting with biliary obstruction and a known lesion of the abdominal vasculature.


Journal of Intensive Care Medicine | 2016

The Complex Surgical Abdomen: What the Nonsurgeon Intensivist Needs to Know.

Wess Cohen; Joel Horovitz; Yizhak Kupfer; Richard H. Savel

Intensivists are often called upon to help care for patients who develop severe sepsis syndrome and septic shock where the primary source is an enterocutaneous fistula (ECF). The purpose of this article is to describe to the nonsurgeon intensivist how these complex surgical situations arise in the first place and provide the reader with a detailed understanding of the potentially devastating complications of ECF. In addition, we will describe a structured algorithm regarding the management of this often highly challenging surgical situation.


Journal of Surgical Research | 1994

Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation.

R. Statman; W. Cheng; Joseph N. Cunningham; J.L. Henderson; Peter Damiani; A. Siconolfi; D. Rogers; Joel Horovitz


Archives of Surgery | 1994

The effects of nitric oxide inhibition on regional hemodynamics during hyperdynamic endotoxemia.

James L. Henderson; Richard Statman; Joseph N. Cunningham; Wang Cheng; Peter Damiani; Anthony Siconolfi; Joel Horovitz


Journal of the Pancreas | 2006

Cystic teratoma of the pancreas: presentation, evaluation and management

Kevin J Koomalsingh; Rafael M Fazylov; Mitchell I. Chorost; Joel Horovitz


Surgery | 2008

Cystic duct biliary adenoma

Adam C. Yopp; Ravi C Pulipati; Mitchell I. Chorost; Joel Horovitz


Journal of The American College of Surgeons | 2003

Metastatic gastrinoma in MEN I syndrome

Valerie Bauer; Joel Horovitz


Annals of medicine and surgery | 2018

Streamlined manuscript submission guidelines: Beyond overdue

Zain A. Sobani; Joel Horovitz; Stephan Kamholz

Collaboration


Dive into the Joel Horovitz's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Peter Damiani

Maimonides Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Scott Tenner

George Washington University

View shared research outputs
Top Co-Authors

Avatar

Zain A. Sobani

Maimonides Medical Center

View shared research outputs
Top Co-Authors

Avatar

A. Siconolfi

Maimonides Medical Center

View shared research outputs
Top Co-Authors

Avatar

Adam C. Yopp

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Alphonso Brown

Maimonides Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge